Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Reevaluating the Role of Cytogenetic Testing in Patients with Suspected Myelodysplastic Syndrome in the Era of Next Generation Sequencing

Eri Kawata, MD PhD, Anargyros Xenocostas, MD FRCPC, Cyrus C. Hsia, MDBSc,FRCPC, Alejandro Lazo-Langner, MD MSc, Kang Howson-Jan, MD FRCPC, Uday Deotare, MBBS, MD DM, Lalit Saini, MD, Benjamin Hedley, PhD, Ping Yang, PhD DABMGG, Michael Levy, PhD, Hanxin Lin, PhD, Bekim Sadikovic, PhD DABMGG, FACMG, Ian Chin-Yee, MD FRCPC

Blood (2019) 134 (Supplement_1): 3438.

https://doi.org/10.1182/blood-2019-128507

Published: 2019

Journal Articles

The Clinical Application of Oncomine Myeloid Next Generation Sequencing (NGS): Comparison of Cytogenetics and NGS in Patients with Suspected Myelodysplastic Syndrome

Eri Kawata, MD PhD, Anargyros Xenocostas, MD FRCPC, Cyrus C. Hsia, MDBSc,FRCPC, Uday Deotare, MBBS, MD DM, Lalit Saini, MD, Ping Yang, PhD DABMGG, Michael Levy, PhD, Hanxin Lin, PhD, Bekim Sadikovic, PhD DABMGG, FACMG, Ian Chin-Yee, MD FRCPC

Blood (2019) 134 (Supplement_1): 3375.

https://doi.org/10.1182/blood-2019-126893

Published: 2019

Journal Articles

The Yield of Echocardiography in the Diagnosis of Infective Endocarditis in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia

Ghazi S. Alotaibi, Irwindeep Sandhu, MD FRCPC, Joseph M. Brandwein, MD FRCPC, Lalit Saini, MD

Blood (2018) 132 (Supplement 1): 5177.

https://doi.org/10.1182/blood-2018-99-120018

Published: 2018

Journal Articles

A Strategy of Day 14 Bone Marrows and Early Intervention Is Associated with Similar Outcomes Compared to a Strategy of No Day 14 Bone Marrows and Delayed Intervention in Patients with Acute Myeloid Leukemia

Osman Radhwi, MD, Joseph M. Brandwein, MD FRCPC, Irwindeep Sandhu, MDFRCPC, Lalit Saini, MD

Blood (2017) 130 (Supplement 1): 2584.

https://doi.org/10.1182/blood.V130.Suppl_1.2584.2584

Published: 2017

Journal Articles

Utility of Leukemic Stem Cells Markers in Determining Minimal Residual Disease in Patients with AML

Mohammad Refaei, MD BSc, MSc, Artur J Szkotak, MD PhD, Irwindeep Sandhu, MDFRCPC, Joseph M. Brandwein, MD FRCPC, Lalit Saini, MD

Blood (2017) 130 (Supplement 1): 3941.

https://doi.org/10.1182/blood.V130.Suppl_1.3941.3941

Published: 2017

Journal Articles

N-Myristoyltransferase 2 (NMT2) Protein Levels Predict Survival in Acute Myeloid Leukemia (AML): A Novel Prognostic Biomarker

Ryan J Stubbins, MDMSc, Zoulika Zak, Aishwarya Iyer, Megan Yap, Krista Vincent, Lynne M Postovit, MD, John R Mackey, MD, Artur J Szkotak, MD PhD, Lalit Saini, MD, Luc G Berthiaume, PhD, Joseph M. Brandwein, MD FRCPC

Blood (2017) 130 (Supplement 1): 3914.

https://doi.org/10.1182/blood.V130.Suppl_1.3914.3914

Published: 2017

Journal Articles

Prognosis and Application of Day 14 Bone Marrow Results in Acute Myeloid Leukemia Induction

James England, MD, Lalit Saini, MD, Donna Hogge, Artur J Szkotak, MD PhD, Joseph M. Brandwein, MD FRCPC, Monika Hudoba, MD, Nadejda Medvedev, MD, Tyler Smith, MD, Roland Kristine, MD, David Sanford, MD

Blood (2017) 130 (Supplement 1): 3917.

https://doi.org/10.1182/blood.V130.Suppl_1.3917.3917

Published: 2017

Journal Articles

Two Cycles of Consolidation Chemotherapy Are Associated with Similar Clinical Outcomes to Three Cycles in AML Patients with Favorable Risk Cytogenetics

Daniel Sawler, MD BSc, David Sanford, MD, Joseph M. Brandwein, MD FRCPC, Irwindeep Sandhu, MDFRCPC, Donna Hogge, Lalit Saini, MD

Blood (2017) 130 (Supplement 1): 464.

https://doi.org/10.1182/blood.V130.Suppl_1.464.464

Published: 2017

Journal Articles

Anticoagulation Prophylaxis in Asparaginase-Based Therapy in Adults with Acute Lymphoblastic Leukemia

Hassan Sibai, MD, Umberto Falcone, MD PhD, Arjun Datt Law, MBBS,MDDM, Naoko Sakurai, Phm, MSc, Lalit Saini, MD, Tian Q Wang, Andrew Stessman, Joseph Samuel, Eshetu G. Atenafu, Ali Hosni, MD, Andre C. Schuh, MD FRCPC, Karen W.L. Yee, MD, Vikas Gupta, MD FRCP, FRCPath, Mark D. Minden, MD PhD, Steven M. Chan, MD PhD, Aaron D. Schimmer, MD PhD, Joseph M. Brandwein, MD FRCPC, Jack T Seki, PharmD

Blood (2016) 128 (22): 1453.

https://doi.org/10.1182/blood.V128.22.1453.1453

Published: 2016

Journal Articles

Use of Tyrosine Kinase Inhibitors Post-Allogeneic Stem Cell Transplant in Patients with Philadelphia or BCR-ABL Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis

Elena Liew, MD, Sunita Ghosh, PhD, P.Stat., Lalit Saini, MD

Blood (2016) 128 (22): 2778.

https://doi.org/10.1182/blood.V128.22.2778.2778

Published: 2016

Journal Articles

Discordance Between Morphologic and Cytogenetic Findings Following Induction Chemotherapy for Acute Myeloid Leukemia Is Prevalent in Patients with Bone Marrow Blasts >2% and Is Associated with Poor Clinical Outcomes

Lalit Saini, MD, Joseph Brandwein, MD FRCPC, Irwindeep Sandhu, MD

Blood (2015) 126 (23): 4978.

https://doi.org/10.1182/blood.V126.23.4978.4978

Published: 2015

Journal Articles

Bone Marrow Aspirates Alone without a Trephine Biopsy May be Insufficient for the Detection of Residual Leukemia Following Intensive Chemotherapy for the Treatment of Acute Myeloid Leukemia

Lalit Saini, MD, Robert Turner, MD, Loree Larratt, MD, Joseph Brandwein, MD, Marlene Ann Hamilton, MD, Anthea Peters, MD MSc, FRCPC, Cynthia M Wu, MD FRCPC, Nancy Zhu, MD, Jeffery M. Patterson, MD, Lauren Bolster, MD, Michael Mant, MD, Bruce Ritchie, MD, Elena Liew, MD, Imran Mirza, MD FRCPC, Graeme R. Quest, MDMSc, Susan Nahirniak, Sunita Gosh, PhD, P.Stat., P.Stat, Irwindeep Sandhu, MD FRCPC

Blood (2014) 124 (21): 2336.

https://doi.org/10.1182/blood.V124.21.2336.2336

Published: 2014

Journal Articles

The FLAG Chemotherapy Regimen Is an Alternative to Anthracycline Based Therapy for the Treatment of Acute Myeloid Leukemia for Patients with Multiple Co-Morbidities or Preexisting Cardiac Disease

Lalit Saini, MD, Robert Turner, MD, Loree Larratt, MD, Joseph Brandwein, MD, Marlene Ann Hamilton, MD, Anthea Peters, MD MSc, FRCPC, Cynthia M. Wu, MD FRCPC, Nancy Zhu, MD, Jeffery M. Patterson, MD, Lauren Bolster, MD, Michael Mant, MD, Bruce Ritchie, MD, Elena Liew, MD, Imran Mirza, MD FRCPC, Graeme R. Quest, MDMSc, Sunita Gosh, PhD, P.Stat., P.Stat, Irwindeep Sandhu, MD FRCPC

Blood (2014) 124 (21): 961.

https://doi.org/10.1182/blood.V124.21.961.961

Published: 2014

Journal Articles

An Evaluation of Septicemia During Outpatient Consolidation Chemotherapy for Acute Myeloid Leukemia

Lalit Saini, MD, Mark D. Minden, MD, PhD, Andre Schuh, MD, Karen Yee, MD, Aaron D Schimmer, MD, PhD, Vikas Gupta, MD, FRCP, FRCPath, Cindy Susan Murray, Joseph Brandwein, MD

Blood (2011) 118 (21): 4268.

https://doi.org/10.1182/blood.V118.21.4268.4268

Published: 2011

NARROW

Reevaluating the Role of Cytogenetic Testing in Patients with Suspected Myelodysplastic Syndrome in the Era of Next Generation Sequencing

The Clinical Application of Oncomine Myeloid Next Generation Sequencing (NGS): Comparison of Cytogenetics and NGS in Patients with Suspected Myelodysplastic Syndrome

The Yield of Echocardiography in the Diagnosis of Infective Endocarditis in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia

A Strategy of Day 14 Bone Marrows and Early Intervention Is Associated with Similar Outcomes Compared to a Strategy of No Day 14 Bone Marrows and Delayed Intervention in Patients with Acute Myeloid Leukemia

Utility of Leukemic Stem Cells Markers in Determining Minimal Residual Disease in Patients with AML

N-Myristoyltransferase 2 (NMT2) Protein Levels Predict Survival in Acute Myeloid Leukemia (AML): A Novel Prognostic Biomarker

Prognosis and Application of Day 14 Bone Marrow Results in Acute Myeloid Leukemia Induction

Two Cycles of Consolidation Chemotherapy Are Associated with Similar Clinical Outcomes to Three Cycles in AML Patients with Favorable Risk Cytogenetics

Anticoagulation Prophylaxis in Asparaginase-Based Therapy in Adults with Acute Lymphoblastic Leukemia

Use of Tyrosine Kinase Inhibitors Post-Allogeneic Stem Cell Transplant in Patients with Philadelphia or BCR-ABL Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis

Discordance Between Morphologic and Cytogenetic Findings Following Induction Chemotherapy for Acute Myeloid Leukemia Is Prevalent in Patients with Bone Marrow Blasts >2% and Is Associated with Poor Clinical Outcomes

Bone Marrow Aspirates Alone without a Trephine Biopsy May be Insufficient for the Detection of Residual Leukemia Following Intensive Chemotherapy for the Treatment of Acute Myeloid Leukemia

The FLAG Chemotherapy Regimen Is an Alternative to Anthracycline Based Therapy for the Treatment of Acute Myeloid Leukemia for Patients with Multiple Co-Morbidities or Preexisting Cardiac Disease

An Evaluation of Septicemia During Outpatient Consolidation Chemotherapy for Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only